OTCMKTS:BCTXF BriaCell Therapeutics (BCTXF) Stock Price, News & Analysis → The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad) Free BCTXF Stock Alerts $2.15 -0.01 (-0.46%) (As of 04/18/2024 ET) Add Compare Share Share Today's Range$2.13▼$2.3550-Day Range$2.16▼$3.9252-Week Range$3.25▼$17.50Volume8,449 shsAverage Volume1,859 shsMarket Capitalization$1.66 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Get BriaCell Therapeutics alerts: Email Address Ad InvestorPlaceNew crypto project uncovers 2,050% in 65 daysDuring the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.Just click here to sign up and be among the first to get it. About BriaCell Therapeutics Stock (OTCMKTS:BCTXF)BriaCell Therapeutics Corp. operates as a clinical-stage biotechnology company that specializes in immunotherapy for advanced breast cancer. It is advancing its targeted immunotherapy program by conducting a Phase I/IIA clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor and a companion diagnostic test, BriaDx, to identify patients to benefit from Bria-IMT. The company was founded by Charles L. Wiseman and Isaac B. Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.Read More BCTXF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BCTXF Stock News HeadlinesFebruary 2, 2024 | msn.comBriaCell’s Shareholders Approve Directors and AuditorsJanuary 4, 2024 | finanznachrichten.deBriaCell Therapeutics Corp.: BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with "Eye-Bulging" Metastatic Breast CancerApril 19, 2024 | Gold Safe Exchange (Ad)The “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.November 15, 2023 | businesswire.comMiNA Therapeutics Highlights Preclinical Research on RNA Activation (RNAa) Therapeutics Presented at the Oligonucleotide Therapeutics Society (OTS) Annual MeetingOctober 25, 2023 | finance.yahoo.comBriaCell Forms Medical Advisory Board of Distinguished Breast Cancer Specialists to Advance its Lead Oncology CandidateOctober 20, 2023 | finance.yahoo.comOctober is Breast Cancer Awareness Month – BriaCell is Leading the Fight with its Innovative TechnologySeptember 26, 2023 | theglobeandmail.comClosing Bell: Briacell Therapeutics Corp flat on Monday (BCT)September 10, 2023 | msn.comBriaCell Therapeutics: Poised To Move To Advanced Trials, But An Unconvincing ThesisApril 19, 2024 | Gold Safe Exchange (Ad)The “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.September 8, 2023 | finance.yahoo.comBriaCell Reports Benchmark-Beating Patient Survival and Clinical Benefit in Advanced Metastatic Breast CancerAugust 18, 2023 | finance.yahoo.comBriaCell Therapeutics Corp. Announces Voting Results From Special MeetingAugust 17, 2023 | msn.comBriaCell receives NCI grant for cancer platform developmentJuly 22, 2023 | theglobeandmail.comBriaCell Therapeutics: Stocks Undervalued by Analyst Consensus on TSX (BCT)June 28, 2023 | markets.businessinsider.comBriaCell Therapeutics (BCT) Gets a Buy Rating from H.C. WainwrightMay 25, 2023 | marketwatch.comBriaCell Therapeutics in Definitive Agreement to Spin Off Certain AssetsMay 25, 2023 | msn.comBriaCell to spin out BriaPro TherapeuticsApril 27, 2023 | theglobeandmail.comBriaCell Therapeutics: Top 25 Performing Stocks Year-to-Date on Toronto Stock Exchange (BCT)April 7, 2023 | theglobeandmail.comClosing Bell: Briacell Therapeutics Corp down on Thursday (BCT)April 1, 2023 | morningstar.comToronto Stocks Advance as Banking Sector Sentiment Improves; BriaCell Slides on Spinoff PlansMarch 30, 2023 | marketwatch.comBriaCell Therapeutics to Spin Off Certain AssetsFebruary 23, 2023 | marketwatch.comBriaCell Sees Positive Survival Data in Ongoing TrialFebruary 23, 2023 | finance.yahoo.comBriaCell Reports Positive Survival Data in Advanced Metastatic Breast CancerJanuary 23, 2023 | marketwatch.comBriaCell to Investigate Potential Stock ManipulationJanuary 12, 2023 | stockhouse.comBriaCell Announces New Patent Issuance, Bria-OTS(TM) IND Timing Guidance, and Additional Clinical Sites to Boost EnrolmentJanuary 10, 2023 | msn.comBriaCell to get US, Australian patent linked to personalized cancer immunotherapyAugust 5, 2022 | bizjournals.comBriaCell signs exclusive licensing deal with UMBC for cancer treatment candidateJuly 21, 2022 | finance.yahoo.comBriaCell Therapeutics Corp. (TSE:BCT) insider upped their holding earlier this yearSee More Headlines Receive BCTXF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BriaCell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolOTCMKTS:BCTXF CUSIPN/A CIKN/A Webwww.briacell.com Phone(604) 921-1810FaxN/AEmployees5Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($3.84) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,680,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-786.77% Debt Debt-to-Equity RatioN/A Current Ratio0.07 Quick Ratio0.07 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($4.55) per share Price / Book-0.47Miscellaneous Outstanding Shares772,000Free FloatN/AMarket Cap$1.66 million OptionableNot Optionable Beta1.09 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesWilliam V. WilliamsPresident, Chief Executive Officer & DirectorGadi LevinChief Financial Officer & SecretaryFarrah DeanManager-Corporate Development & IR ContactKey CompetitorsGRI BioNASDAQ:GRIPeak PharmaceuticalsOTCMKTS:PKPHAcerus PharmaceuticalsOTCMKTS:ASPCFMallinckrodtOTCMKTS:MNKKQPanbela TherapeuticsNASDAQ:PBLAView All Competitors BCTXF Stock Analysis - Frequently Asked Questions How have BCTXF shares performed in 2024? BriaCell Therapeutics' stock was trading at $5.85 on January 1st, 2024. Since then, BCTXF shares have decreased by 63.3% and is now trading at $2.1476. View the best growth stocks for 2024 here. How do I buy shares of BriaCell Therapeutics? Shares of BCTXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:BCTXF) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceUrgent alert: open this for a huge profit potentialTimothy SykesHow Biden has already won 2024Porter & CompanyOptions trading has suddenly become more reliable.Eagle Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BriaCell Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.